Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Select Advanced Solid Tumors × tebentafusp × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 2 Uveal Melanoma 1 Select Advanced Solid Tumors 1 Diabetes Mellitus, Insulin-Dependent, 12 1

Interventions

tebentafusp 1 pembrolizumab 1 fludarabine 1 atezolizumab 1 Interleukin-2 1 Drug Therapy 1 Cyclophosphamide 1 Bevacizumab 1 Antibodies, Monoclonal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04262466 2026-03-06

Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors

Immunocore Ltd

Phase 1/2 Active not recruiting

Other solid neoplasm

Select Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡